Parsons Bags Multi-Year, $21M US Army Contract For Munitions Response

Defense company Parsons Corp (NYSE: PSN) has bagged a contract from the U.S. Army Corps of Engineers (USACE) Los Angeles District on the Camp San Luis Obispo (CSLO) Munitions Response Site (MRS) 05.

Defense company Parsons Corp (NYSE:PSN) has bagged a contract from the U.S. Army Corps of Engineers (USACE) Los Angeles District on the Camp San Luis Obispo (CSLO) Munitions Response Site (MRS) 05.

The contract, spanning five years, has a ceiling value of $21 million and is new work for the company.

Parsons will serve as a subcontractor to the prime contractor PIKA-Insight joint venture (JV) LLC, and will conduct advanced geophysical classification (AGC) data collection.

The USACE Los Angeles District provides civil works and military engineering support to Southern California, Nevada, Arizona, and parts of Utah. 

USACE Los Angeles maintains responsibilities for CSLO MRS 05 as the site is part of the Formerly Used Defense Sites (FUDS) Program and requires environmental remediation.

Parsons will use its AGC capabilities and deep domain expertise to collect and analyze data vital to the proposed remedial action.

Price Action: PSN shares closed lower by 0.09% at $62.96 on Friday.

Photo Via Company

Total
0
Shares
Related Posts
Read More

Tilray Ramps Up Its Cannabis Portfolio In Canada, Wins International Spirits Competition

Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) announced on Thursday the launch of 'Purple Churro,' by Redecan cannabis.The new sativa offers "a sweet, indulgent experience with a potent twist and boasting THC levels," the Canadian cannabis giant said in a press release.Purple Churro is a cross of Cinnamon Horchata and Apples & Bananas, featuring a blend of sweet vanilla and cinnamon-tasting notes.In the meantime, the company's liquor business is celebrating two wins at the 15th annual New York International Spirits Competition. Tilray's subsidiary Breckenridge Distillery was a winner at Colorado American Blended Whiskey Distillery of the Year and Double Gold for Breckenridge Port Cask Finish.

TLRY

Read More

CytoMed Therapeutics Announces China Research Collaboration To Enhance Its Allogeneic CAR γδ T In Vivo Persistency; The MOU Signed By Cytomed And Hangzhou CNK Therapeutics Co., Ltd Is The First Of Several Collaborative Efforts In North Asia

The MOU signed by CytoMed and Hangzhou CNK Therapeutics Co., Ltd is the first of several collaborative efforts in North Asia.   SINGAPORE, Aug. 15, 2023 /PRNewswire/ -- CytoMed Therapeutics

GDTC